Navigation Links
PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
Date:5/17/2012

LAKE FOREST, Ill., May 17, 2012 /PRNewswire/ -- Amy Langan, Vice President of Marketing and Business Development, announced that PharMEDium will highlight its enhanced labeling for sterile intravenous compounded ICU Services at the National Teaching Institute (NTI) and Critical Care Exposition, May 19-24, 2012 in Orlando, Florida.

(Logo: http://photos.prnewswire.com/prnh/20120517/CG09355LOGO)

Ms. Langan invites critical care professionals to visit Booth #2668 to see how the enhanced labels help clinicians and pharmacy staff with easier drug and dose recognition when stocking, retrieving, and administering compounded services from PharMEDium.  Onsite PharMEDium associates will showcase the functionality and appearance of the enhanced labels and packaging, which are resultant of PharMEDium's ongoing commitment to patient safety, quality and innovation.

"Attendees at the NTI and Critical Care Exposition anticipate seeing new ideas, approaches and innovations designed to help them provide patient safety and quality of care for critically ill patients," stated David N. Jonas, CEO and Chairman of the Board.   "As the key educational and informational event for critical care caregivers, this meeting is an ideal forum for PharMEDium to present our new and enhanced labeling for ICU services."

At the 2011 Chicago exposition, PharMEDium conducted market research with over 1000 critical care nurses, enabling PharMEDium to gain a broader understanding of the medication administration challenges critical care nurses face.  The findings were the foundation for several of the enhancements now in the market. For example, service being delivered with new labels includes Phenylephrine, Norepinephrine and Vasopressin ready-to-use compounded sterile preparations.  David N. Jonas, PharMEDium Chairman and CEO, added, "We have received positive feedback about the labeling enhancements.  We're enthusiastic to be a part of this professional group and PharMEDium is proud to be a corporate sponsor of the American Association of Critical Care Nurses."

About PharMEDium
PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium® network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and federal regulations, including USP Chapter (797), and DEA requirements.  For more information on PharMEDium, visit http://www.pharmedium.com.

 


'/>"/>
SOURCE PharMEDium
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharMEDium Adds O.R. Medication Verification System
2. PharMEDiums Technology Helps Hospital Pharmacists Ensure Safety
3. PharMEDium Unveils Drug Shortage and Usage Updates on New Website with Focus on Patient Safety
4. PharMEDium Services, LLC Receives U.S. Patent 7,918,830 Entitled Safety Device for Drug Delivery Devices and Containers
5. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
6. PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia
7. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
8. PharMEDium Elects William R. Spalding to Board of Directors
9. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
10. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
11. Delcath Highlights First Quarter 2012 And Recent Accomplishments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... DIEGO , Feb. 8, 2016 /PRNewswire/--  Cell ... announced that advanced tissue-engineering services are now available ... a groundbreaking new three-dimensional (3D) bioprinting approach called ... 3D Bio Printer , a state-of-the-art robotic system ... has created a powerful pay-for-service bio-printing model that ...
(Date:2/8/2016)... 8, 2016 Velano Vascular, a medical technology ... patients and their practitioners, announced today that the company ... will use the proceeds from this financing, an extension ... January 2015, to support the development and commercialization of ... populations. Philadelphia , and ...
(Date:2/8/2016)... 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS ... delivery systems, today announced that it will release its financial ... 2015 after market close on February 9, 2016.  At this ... discuss these financial results.    About Unilife Corporation ... About Unilife Corporation UNIS ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California ... combat pancreatic cancer. , Gary D. Radine, who recently retired as president and CEO ... Cancer Society’s 2015 CEO of the Year , helped lead the effort to ...
(Date:2/8/2016)... ... , ... FileHold's document management software has been implemented by ... environment for FileHold software that is pay per user subscription-based and also does ... FileHold web services API. DocuSyst also advises clients on fully functioning back up ...
(Date:2/8/2016)... ... February 08, 2016 , ... TopConsumerReviews.com recently awarded their highest ... products. , Moles are derived from a cluster of melanin when exposed to sunlight. ... places and create a lifetime of embarrassment. Historically, mole removal has involved ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... four states in the U.S. require dental technicians to be certified or obtain ... dental industry, NADL created the “What’s In Your Mouth?” campaign to inform dentists ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
Breaking Medicine News(10 mins):